Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

 

VIA EDGAR

 

November 12, 2024

 

U.S. Securities and Exchange Commission

Office of Life Sciences

Washington, D.C. 20549

Attn: Joshua Gorsky, Tim Buchmiller

 

	Re:		Onconetix, Inc.
			Registration Statement on Form S-1
			Filed November 1, 2024
			File No. 333-282959

 

 

Ladies and Gentleman,

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. EST on Tuesday, November 12, 2024, or as soon as thereafter practicable.

 

Very truly yours,

/s/ Karina M. Fedasz

By: Karina M. Fedasz

Title: Interim Chief Financial Officer

 

cc:

Ellenoff Grossman & Schole LLP